Ketoconazole does not appear to be beneficial in acute lung injury or ARDS (acute respiratory distress syndrome)

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1235, 2000-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome

By Bosma Karen J   Lewis James F  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 3, 2007-09 ,pp. : 461-477

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of Acute Lung Injury and Acute Respiratory Distress Syndrome

By  

Current Medicinal Chemistry, Vol. 15, Iss. 19, 2008-01 ,pp. : 1911-1924

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic Inflammatory Diseases and the Acute Respiratory Distress Syndrome (ARDS)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1400-1408

Bentham Science Publishers

Access to resources Recommend Favorite

Activated protein C in the treatment of acute lung injury and acute respiratory distress syndrome

By Cornet Alexander D   van Nieuw Amerongen Geerten P   Beishuizen Albertus   Schultz Marcus J   Girbes Armand RJ   Groeneveld AB Johan  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 3, 2009-03 ,pp. : 219-227

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Modulation of Coagulation and Fibrinolysis in Acute Lung Injury and the Acute Respiratory Distress Syndrome

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 9, 2011-09 ,pp. : 1481-1496

Bentham Science Publishers

Access to resources Recommend Favorite